Skip to main content
Log in

Economic burden of CF substantial in Germany, and likely to rise

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. CF transmembrane conductance regulator

  2. CF transmembrane conductance regulator

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Economic burden of CF substantial in Germany, and likely to rise. PharmacoEcon Outcomes News 826, 12 (2019). https://doi.org/10.1007/s40274-019-5814-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5814-9

Navigation